Jill W. Alty

Jill W. Alty

Auto-generated profile, based on publicly available information

Jill W. Alty

Department of Chemistry, Massachusetts Institute of Technology; Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
CJCoralie Jehanno
Coralie Jehanno
JAJill W. Alty
Jill W. Alty
MRMartijn Roosen
Martijn Roosen
SMSteven De Meester
Steven De Meester
ADAndrew P. Dove
Andrew P. Dove
Haritz SardonHaritz Sardon
Haritz Sardon

3 February 2022 in Science
Verified
Journal Article
Closed access
TFTimothy J. Fazekas
Timothy J. Fazekas
JAJill W. Alty
Jill W. Alty
ENEliza K. Neidhart
Eliza K. Neidhart
AMAustin S. Miller
Austin S. Miller
FLFrank A. Leibfarth
Frank A. Leibfarth
EAErik J. Alexanian
Erik J. Alexanian
The ability to selectively introduce diverse functionality onto hydrocarbons is of substantial value in the synthesis of both small molecules and polymers. Herein, we report an approach to aliphatic carbon–hydrogen bond diversification using radical chain transfer featuring an easily prepared O -alkenylhydroxamate reagent, which upon mild heating facilitates a range of challenging or previously undeveloped aliphatic carbon–hydrogen bond functionalizations of small molecules and polyolefins. This broad reaction platform enabled the functionalization of postconsumer polyolefins in infrastructure used to process plastic waste. Furthermore, the chemoselective placement of ionic functionality onto a branched polyolefin using carbon–hydrogen bond functionalization upcycled the material from a thermoplastic into a tough elastomer with the tensile properties of high-value polyolefin ionomers.

1 June 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ENEliza K. Neidhart
Eliza K. Neidhart
MPMichelle E. Pomatto
Michelle E. Pomatto
CVChris Vasallo
Chris Vasallo
ECErin R. Crater
Erin R. Crater
JAJill W. Alty
Jill W. Alty
FLFrank A. Leibfarth
Frank A. Leibfarth

2 June 2025 in ACS Central Science
Verified
Journal Article
Open access
JAJill W. Alty
Jill W. Alty
CBCarolyn E. Barnes
Carolyn E. Barnes
ANAgnese M. Nicoli
Agnese M. Nicoli
BTBradley S. Turner
Bradley S. Turner
EBEkua A. Beneman
Ekua A. Beneman
LKLaura L. Kiessling
Laura L. Kiessling
The human microbiome contains at least as many bacterial cells as human cells. Some bacteria offer benefits, like improving gut barrier function, suppressing pathobiont growth, and modulating immunity. These benefits have popularized probiotics, but probiotic retention is often hindered by low colonization efficiency in the mucosal layer that lines all epithelial cells. Mucins, the primary components of mucus, are essential for the organization and regulation of microbial populations. The molecular mechanisms of mucin–probiotic interactions remain understudied due, in part, to the inability to incisively manipulate native mucin sequences or their glycans. Here, we used synthetic mucins with defined glycan presentations to interrogate glycan-dependent interactions between mucus and three probiotic lactobacilli species. The nutrient conditions under which bacteria were cultured influenced glycan binding preferences, suggesting mucin–probiotic interactions change with nutrient availability. The addition of synthetic mucins to native mucin increased Limosilactobacillus fermentum adherence. Additionally, an increase in glycosidase activity indicated that native and synthetic mucins function as prebiotics, as probiotic bacteria can cleave the displayed O-glycans. Thus, synthetic mucins can cultivate target probiotic bacteria and increase adhesion as binding sites, highlighting their value as tools for elucidating native mucin functions and as promising agents for promoting human health.

1 June 2025 in Angewandte Chemie
Verified
Journal Article
Closed access
ENEliza K. Neidhart
Eliza K. Neidhart
MPMichelle E. Pomatto
Michelle E. Pomatto
CVChris Vasallo
Chris Vasallo
ECErin R. Crater
Erin R. Crater
JAJill W. Alty
Jill W. Alty
FLFrank A. Leibfarth
Frank A. Leibfarth

29 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJill W. Alty
Jill W. Alty
CBCarolyn E. Barnes
Carolyn E. Barnes
ANAgnese Nicoli
Agnese Nicoli
BTBradley S. Turner
Bradley S. Turner
EBEkua A Beneman
Ekua A Beneman
LKLaura L. Kiessling
Laura L. Kiessling
The human microbiome contains at least as many bacterial cells as human cells. The mucosal layer that lines all epithelial cells organizes, cultivates, and regulates these bacterial inhabitants. Some commensal bacteria offer benefits, like improving gut barrier function, suppressing pathobiont growth, and modulating host immunity. These health benefits have fueled the popularity of probiotics, but their retention is often hindered by their low colonization efficiency and mucosal adhesion. Mucins, the primary structural components of the mucosal layer, are essential for the organization and regulation of microbial populations, promoting growth and offering sites for adhesion through their multivalent presentation of O-glycosylation. The molecular mechanisms of mucin– probiotic interactions remain understudied due, in part, to the inability to incisively manipulate native mucin sequences or the glycans they bear. In this investigation, we developed synthetic mucins with defined glycan presentations to interrogate glycan-dependent interactions between mucus and probiotic Lactobacillus species. Though synthetic mucins can dampen the effects of pathogens, toxins, and viruses, their impact on probiotic bacteria as prebiotics or binding sites is unclear. We synthesized mucin surrogates that bind to three investigated Lactobacillus species. The nutrient conditions under which bacteria were cultured influenced glycan binding preferences, suggesting mucin–probiotic interactions change with nutrient availability. The addition of synthetic mucins to native mucin increased Lactobacillus fermentum adherence. Additionally, an increase in Lactobacillus glycosidase activity indicated that native and synthetic mucins both function as prebiotics, as probiotic bacteria can cleave the displayed O-glycans. Thus, synthetic mucins can cultivate target probiotic bacteria and increase adhesion as binding sites, highlighting their value as tools for elucidating native mucin functions and as promising agents for promoting human health.